VRDN stock results show that Viridian Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
Articles
LCII Stock Earnings: LCI Indus Beats EPS, Beats Revenue for Q1 2024
LCII stock results show that LCI Indus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q1 2024
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. More
MRNS Stock Earnings: Marinus Pharma Misses EPS, Misses Revenue for Q1 2024
MRNS stock results show that Marinus Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
VERX Stock Earnings: Vertex Beats EPS, Beats Revenue for Q1 2024
VERX stock results show that Vertex beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
GILT Stock Earnings: Gilat Satellite Networks Beats EPS, Misses Revenue for Q1 2024
GILT stock results show that Gilat Satellite Networks beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
TRIP Stock Earnings: TripAdvisor Beats EPS, Beats Revenue for Q1 2024
TRIP stock results show that TripAdvisor beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More